Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Authors Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T

Received 12 April 2018

Accepted for publication 12 April 2018

Published 22 May 2018 Volume 2018:14 Pages 1307—1308

DOI https://doi.org/10.2147/NDT.S170901


Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.

On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients” it should have been “Differences of the ESS scores and MSL between decreased and normal CSF orexin groups were insignificant among DM1 patients”.

Read the original article
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]